Alpha-2 Receptor Agonists Market Share

  • Report ID: 3265
  • Published Date: May 09, 2024
  • Report Format: PDF, PPT

Alpha-2 Receptor Agonists Market Share

North American Market Forecast

By 2036, North America region is expected to account for around 45% alpha-2 receptor agonists market share. This growth can be impelled by the growing number of people suffering from attention-deficit/hyperactivity disorder (ADHD). In the United States, nearly 8.7 million adults in the United States are dealing with this disorder. Around 60% of children with ADHD in the US also have at least one other mental, emotional, or behavioral condition, such as depression or anxiety. In addition, an estimated 77% of children diagnosed with ADHD in the United States receive treatment.

APAC Market Statistics

The market in Asia Pacific is predicted to garner significant revenue share during forecast period. The incidence of hypertension-related disorders is on the rise and is a growing concern in the Asian region. The use of alpha-2 receptor agonists is becoming increasingly common, as the prevalence of hypertension in urban adult populations of Asia has been found to vary between 15-35%, as per new criteria (140/90 mm Hg).

Research Nester
Alpha-2 Receptor Agonists Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3265
  • Published Date: May 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of hypertension, growing awareness regarding ADHD, the rising aging population, and growing adoption of pain management solutions are some of the major growth drivers for the alpha-2 receptor agonists market.

The market size of Alpha-2 Receptor Agonists is anticipated to attain a CAGR of 8.7 % over the forecast period, i.e., 2024-2036.

The major players in the market are Pfizer Inc., Merck & Co., Inc., Viatris Inc., Amneal Pharmaceuticals LLC., Unichem Pharmaceuticals USA INC, Seqens Group, Teva Pharmaceuticals USA, Inc., Ajanta Pharma Ltd., Boehringer Ingelheim International GmbH., Otsuka Pharmaceutical Co., Ltd., and others.

The Hypertension segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample